SARS-CoV-2: From Genetic Variability to Vaccine Design

SARS-CoV-2: From Genetic Variability to Vaccine Design PDF Author: Indrajit Saha
Publisher: Frontiers Media SA
ISBN: 2832501761
Category : Science
Languages : en
Pages : 165

Get Book Here

Book Description

SARS-CoV-2: From Genetic Variability to Vaccine Design

SARS-CoV-2: From Genetic Variability to Vaccine Design PDF Author: Indrajit Saha
Publisher: Frontiers Media SA
ISBN: 2832501761
Category : Science
Languages : en
Pages : 165

Get Book Here

Book Description


Co-Evolution Between New Coronavirus (SARS-CoV-2) and Genetic Diversity

Co-Evolution Between New Coronavirus (SARS-CoV-2) and Genetic Diversity PDF Author: Mahmood A. Al-Azzawi
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 0

Get Book Here

Book Description
The DNA sequences are different between the distinct individuals and these variations produce the species genetic diversity. SARS-CoV-2 virus is a zoonotic SARS-like coronavirus that spreads globally, causing the COVID-19 pandemic disease. The immune response genes are the most various and different in the human genome, correlating with infectious diseases. Genetic variants in the angiotensin-converting enzyme 2 (ACE2) receptor, TMPRSS2, HO-1, BCL11A, and CYP2D6 are predicted to either encourage or inhibit the interaction with the viral proteins and subsequently contribute to coronavirus genetic risk factors. The genetic susceptibility to SARS-CoV-2 was investigated by analyzing different genes,Äô polymorphisms such as ACE2 and TMPRSS2, HO-1, and BCL11A. A specific genetic susceptibility to COVID-19 was found through different populations in TMPRSS2, ACE2, HO-1, and BCL11A genes. Particularly, ACE2 gene polymorphisms were shown to be correlated with pulmonary and cardiovascular conditions by modifying the angiotensinogen-ACE2 system, which recommends the possible explanations of COVID-19 susceptibility based on genetic diversity. Moreover, the COVID-19 treatment could be complicated by such genetic polymorphisms. In conclusion, a good characterization of functional polymorphisms and the host genetics can assist in identifying the pathophysiology of the disease pathway to stratify the risk evaluation and to personalize the treatment procedures.

Structural Virology

Structural Virology PDF Author: Mavis Agbandje-McKenna
Publisher: Royal Society of Chemistry
ISBN: 184973223X
Category : Medical
Languages : en
Pages : 389

Get Book Here

Book Description
Over the last ten years, much effort has been devoted to improving the biophysical techniques used in the study of viruses. This has resulted in the visualization of these large macromolecular assemblages at atomic level, thus providing the platform for functional interpretation and therapeutic design. Structural Virology covers a wide range of topics and is split into three sections. The first discusses the vast biophysical methodologies used in structural virology, including sample production and purification, confocal microscopy, mass spectrometry, negative-stain and cryo-electron microscopy, X-ray crystallography and nuclear magnetic resonance spectroscopy. The second discusses the role of virus capsid protein structures in determining the functional roles required for receptor recognition, cellular entry, capsid assembly, genome packaging and mechanisms of host immune system evasion. The last section discusses therapeutic strategies based on virus protein structures, including the design of antiviral drugs and the development of viral capsids as vehicles for foreign gene delivery. Each topic covered will begin with a review of the current literature followed by a more detailed discussion of experimental procedures, a step in the viral life cycle, or strategies for therapeutic development. With contributions from experts in the field of structural biology and virology this exceptional monograph will appeal to biomedical scientists involved in basic and /or applied research on viruses. It also provides up-to-date reference material for students entering the field of structural virology as well as scientists already familiar with the area.

Flexible Viruses

Flexible Viruses PDF Author: Vladimir Uversky
Publisher: John Wiley & Sons
ISBN: 0470618310
Category : Science
Languages : en
Pages : 532

Get Book Here

Book Description
This book provides up-to-date information on experimental and computational characterization of the structural and functional properties of viral proteins, which are widely involved in regulatory and signaling processes. With chapters by leading research groups, it features current information on the structural and functional roles of intrinsic disorders in viral proteomes. It systematically addresses the measles, HIV, influenza, potato virus, forest virus, bovine virus, hepatitis, and rotavirus as well as viral genomics. After analyzing the unique features of each class of viral proteins, future directions for research and disease management are presented.

CRISPR-Cas Systems

CRISPR-Cas Systems PDF Author: Rodolphe Barrangou
Publisher: Springer Science & Business Media
ISBN: 364234657X
Category : Science
Languages : en
Pages : 300

Get Book Here

Book Description
CRISPR/Cas is a recently described defense system that protects bacteria and archaea against invasion by mobile genetic elements such as viruses and plasmids. A wide spectrum of distinct CRISPR/Cas systems has been identified in at least half of the available prokaryotic genomes. On-going structural and functional analyses have resulted in a far greater insight into the functions and possible applications of these systems, although many secrets remain to be discovered. In this book, experts summarize the state of the art in this exciting field.

The Coronaviridae

The Coronaviridae PDF Author: Stuart G. Siddell
Publisher: Springer Science & Business Media
ISBN: 1489915311
Category : Medical
Languages : en
Pages : 424

Get Book Here

Book Description
Coronaviruses were recognized as a group of enveloped, RNA viruses in 1968 and accepted by the International Committee on the Taxonomy of Viruses as a separate family, the Coronaviridae, in 1975. By 1978, it had become evident that the coronavirus genomic RNA was infectious (i. e. , positive strand), and by 1983, at least the framework of the coronavirus replication strategy had been per ceived. Subsequently, with the application of recombinant DNA techniques, there have been remarkable advances in our understanding of the molecular biology of coronaviruses, and a mass of structural data concerning coronavirus genomes, mRNAs, and pro teins now exists. More recently, attention has been focused on the role of essential and accessory gene products in the coronavirus replication cyde and a molecular analysis of the structure-function relation ships of coronavirus proteins. Nevertheless, there are still large gaps in our knowledge, for instance, in areas such as the genesis of coronavirus subgenomic mRNAs or the function of the coronavirus RNA-dependent RNA polymerase. The diseases caused by coronaviruses have been known for much longer than the agents themselves. Possibly the first coronavirus-related disease to be recorded was feline infectious peritonitis, as early as 1912. The diseases associ ated with infectious bronchitis virus, transmissible gastroenteritis virus, and murine hepatitis virus were all well known before 1950.

Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19) PDF Author: Shailendra K. Saxena
Publisher:
ISBN: 9789811548154
Category : Coronavirus infections
Languages : en
Pages :

Get Book Here

Book Description
This book provides a comprehensive overview of recent novel coronavirus (SARS-CoV-2) infection, their biology and associated challenges for their treatment and prevention of novel Coronavirus Disease 2019 (COVID-19). Discussing various aspects of COVID-19 infection, including global epidemiology, genome organization, immunopathogenesis, transmission cycle, diagnosis, treatment, prevention, and control strategies, it highlights host-pathogen interactions, host immune response, and pathogen immune invasion strategies toward developing an immune intervention or preventive vaccine for COVID-19. An understanding of the topics covered in the book is imperative in the context of designing strategies to protect the human race from further losses and harm due to SARS-CoV-2 infection causing COVID-19.

Immunoinformatics

Immunoinformatics PDF Author: Christian Schönbach
Publisher: Springer Science & Business Media
ISBN: 0387729682
Category : Medical
Languages : en
Pages : 216

Get Book Here

Book Description
In contrast to existing books on immunoinformatics, this volume presents a cross-section of immunoinformatics research. The contributions highlight the interdisciplinary nature of the field and how collaborative efforts among bioinformaticians and bench scientists result in innovative strategies for understanding the immune system. Immunoinformatics is ideal for scientists and students in immunology, bioinformatics, microbiology, and many other disciplines.

The Evolution and Emergence of RNA Viruses

The Evolution and Emergence of RNA Viruses PDF Author: Edward C. Holmes
Publisher: Oxford University Press
ISBN: 0199211124
Category : Language Arts & Disciplines
Languages : en
Pages : 267

Get Book Here

Book Description
While the study of viral evolution has developed rapidly in the last 30 years, little attention has been directed toward linking the mechanisms of viral evolution to the epidemiological outcomes of these processes. This book intends to fill this gap by considering the patterns and processes of viral evolution at all its spatial and temporal scales.

Potential Risks and Benefits of Gain-of-Function Research

Potential Risks and Benefits of Gain-of-Function Research PDF Author: National Research Council
Publisher: National Academies Press
ISBN: 0309367867
Category : Science
Languages : en
Pages : 131

Get Book Here

Book Description
On October 17, 2014, spurred by incidents at U.S. government laboratories that raised serious biosafety concerns, the United States government launched a one-year deliberative process to address the continuing controversy surrounding so-called "gain-of-function" (GOF) research on respiratory pathogens with pandemic potential. The gain of function controversy began in late 2011 with the question of whether to publish the results of two experiments involving H5N1 avian influenza and continued to focus on certain research with highly pathogenic avian influenza over the next three years. The heart of the U.S. process is an evaluation of the potential risks and benefits of certain types of GOF experiments with influenza, SARS, and MERS viruses that would inform the development and adoption of a new U.S. Government policy governing the funding and conduct of GOF research. Potential Risks and Benefits of Gain-of-Function Research is the summary of a two-day public symposia on GOF research. Convened in December 2014 by the Institute of Medicine and the National Research Council, the main focus of this event was to discuss principles important for, and key considerations in, the design of risk and benefit assessments of GOF research. Participants examined the underlying scientific and technical questions that are the source of current discussion and debate over GOF research involving pathogens with pandemic potential. This report is a record of the presentations and discussion of the meeting.